Dr. Lorinda Chung, MD

NPI: 1427026442
Total Payments
$56,883
2024 Payments
$3,610
Companies
10
Transactions
83
Medicare Patients
309
Medicare Billing
$42,525

Payment Breakdown by Category

Consulting$48,288 (84.9%)
Travel$4,774 (8.4%)
Other$1,913 (3.4%)
Food & Beverage$1,725 (3.0%)
Education$183.16 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $48,288 20 84.9%
Travel and Lodging $4,774 20 8.4%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,913 7 3.4%
Food and Beverage $1,725 31 3.0%
Education $183.16 5 0.3%

Top Paying Companies

Company Total Records Latest Year
Boehringer Ingelheim Pharmaceuticals, Inc. $21,779 27 $0 (2024)
MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC. $14,383 14 $0 (2022)
Boehringer Ingelheim International GmbH $7,671 9 $0 (2020)
E.R. Squibb & Sons, L.L.C. $5,735 13 $0 (2018)
Genentech, Inc. $2,750 5 $0 (2024)
Eli Lilly and Company $1,600 1 $0 (2023)
Actelion Pharmaceuticals US, Inc. $1,550 1 $0 (2022)
Amgen Inc. $532.17 10 $0 (2020)
ABBVIE INC. $483.39 2 $0 (2024)
Incyte Corporation $400.00 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,610 6 Boehringer Ingelheim Pharmaceuticals, Inc. ($2,526)
2023 $1,600 1 Eli Lilly and Company ($1,600)
2022 $5,438 6 MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC. ($2,400)
2021 $1,000 2 Genentech, Inc. ($1,000)
2020 $8,812 19 Boehringer Ingelheim Pharmaceuticals, Inc. ($7,401)
2019 $14,666 15 Boehringer Ingelheim Pharmaceuticals, Inc. ($9,449)
2018 $21,588 31 Mitsubishi Tanabe Pharma Development America, Inc. ($9,739)
2017 $169.00 3 Mitsubishi Tanabe Pharma Development America, Inc. ($169.00)

All Payment Transactions

83 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/23/2024 ABBVIE INC. Travel and Lodging In-kind items and services $432.49 General
12/17/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $1,960.00 General
12/09/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $432.49 General
11/14/2024 ABBVIE INC. Food and Beverage In-kind items and services $50.90 General
11/13/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $133.85 General
01/18/2024 Genentech, Inc. Consulting Fee Cash or cash equivalent $600.00 General
09/25/2023 Eli Lilly and Company Consulting Fee Cash or cash equivalent $1,600.00 General
12/20/2022 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $338.12 General
Category: RESPIRATORY
12/16/2022 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug) Consulting Fee Cash or cash equivalent $1,550.00 General
Category: Cardiology
10/24/2022 Genentech, Inc. Consulting Fee Cash or cash equivalent $150.00 General
07/27/2022 Genentech, Inc. Consulting Fee Cash or cash equivalent $1,000.00 General
07/08/2022 MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC. Consulting Fee Cash or cash equivalent $1,200.00 General
04/28/2022 MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC. Consulting Fee Cash or cash equivalent $1,200.00 General
08/19/2021 Genentech, Inc. Consulting Fee Cash or cash equivalent $500.00 General
03/09/2021 Genentech, Inc. Consulting Fee Cash or cash equivalent $500.00 General
10/25/2020 Boehringer Ingelheim International GmbH OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $390.69 General
Category: RESPIRATORY
10/12/2020 Boehringer Ingelheim Pharmaceuticals, Inc. Education In-kind items and services $7.08 General
08/27/2020 Boehringer Ingelheim International GmbH OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $183.85 General
Category: RESPIRATORY
07/23/2020 Boehringer Ingelheim Pharmaceuticals, Inc. Education In-kind items and services $7.08 General
06/04/2020 Boehringer Ingelheim International GmbH OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $505.55 General
Category: RESPIRATORY
03/30/2020 Boehringer Ingelheim International GmbH OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $217.27 General
Category: RESPIRATORY
02/25/2020 Amgen Inc. Food and Beverage In-kind items and services $16.64 General
02/19/2020 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Consulting Fee Cash or cash equivalent $5,450.00 General
Category: RESPIRATORY
02/19/2020 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Travel and Lodging In-kind items and services $140.00 General
Category: RESPIRATORY
02/19/2020 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $35.00 General
Category: RESPIRATORY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 95 120 $38,896 $13,209
2022 3 72 98 $32,570 $11,149
2021 3 75 99 $40,832 $11,303
2020 3 67 82 $35,595 $6,864
Total Patients
309
Total Services
399
Medicare Billing
$42,525
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 45 61 $19,566 $7,728 39.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 26 34 $9,376 $2,754 29.4%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 12 12 $3,048 $1,643 53.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 12 13 $6,906 $1,084 15.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 35 55 $16,288 $6,562 40.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 24 30 $12,980 $2,446 18.8%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 13 13 $3,302 $2,141 64.8%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 31 45 $18,270 $5,283 28.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 27 37 $16,744 $3,194 19.1%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 17 17 $5,818 $2,826 48.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 33 45 $15,972 $2,814 17.6%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 22 25 $11,858 $2,205 18.6%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 12 12 $7,765 $1,845 23.8%

About Dr. Lorinda Chung, MD

Dr. Lorinda Chung, MD is a Internal Medicine healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427026442.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lorinda Chung, MD has received a total of $56,883 in payments from pharmaceutical and medical device companies, with $3,610 received in 2024. These payments were reported across 83 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($48,288).

As a Medicare-enrolled provider, Chung has provided services to 309 Medicare beneficiaries, totaling 399 services with total Medicare billing of $42,525. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Rheumatology
  • Location Palo Alto, CA
  • Active Since 03/08/2006
  • Last Updated 04/28/2024
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1427026442

Products in Payments

  • OFEV (Drug) $26,507
  • ORENCIA (Biological) $5,735
  • OPSUMIT (Drug) $1,550
  • Enbrel (Biological) $370.16
  • Prolia (Biological) $56.65
  • EVENITY (Biological) $46.79
  • NINTEDANIB (Drug) $37.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Palo Alto